相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Systematic review and meta-analysis of potential pleiotropic effects of sevelamer in chronic kidney disease: Beyond phosphate control
Roopa Satyanarayan Basutkar et al.
NEPHROLOGY (2022)
The impact of phosphate lowering agents on clinical and laboratory outcomes in chronic kidney disease patients: a systematic review and meta-analysis of randomized controlled trials
Jeerath Phannajit et al.
JOURNAL OF NEPHROLOGY (2022)
The global burden of kidney disease and the sustainable development goals
Valerie A. Luyckx et al.
BULLETIN OF THE WORLD HEALTH ORGANIZATION (2018)
The role of calcium and non calcium-based phosphate binders in chronic kidney disease
Grahame J. Elder et al.
NEPHROLOGY (2017)
Randomized Clinical Trial of Sevelamer Carbonate on Serum Klotho and Fibroblast Growth Factor 23 in CKD
Sophie Liabeuf et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2017)
Phosphate binders in chronic kidney disease: a systematic review of recent data
Juergen Floege
JOURNAL OF NEPHROLOGY (2016)
Structural mechanism of ligand activation in human calcium-sensing receptor
Yong Geng et al.
ELIFE (2016)
The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations
Brian Hutton et al.
ANNALS OF INTERNAL MEDICINE (2015)
Pathophysiology of Calcium, Phosphorus, and Magnesium Dysregulation in Chronic Kidney Disease
Arnold J. Felsenfeld et al.
SEMINARS IN DIALYSIS (2015)
Association of C-reactive protein, tumor necrosis factor-alpha, and interleukin-6 with chronic kidney disease
Belinda T. Lee et al.
BMC NEPHROLOGY (2015)
Roles of phosphate and fibroblast growth factor 23 in cardiovascular disease
Julia J. Scialla et al.
NATURE REVIEWS NEPHROLOGY (2014)
Long-term sevelamer treatment lowers serum fibroblast growth factor 23 accompanied with increasing serum Klotho levels in chronic haemodialysis patients
Hsin-Hung Lin et al.
NEPHROLOGY (2014)
New Insights Into the FGF23-Klotho Axis
Hannes Olauson et al.
SEMINARS IN NEPHROLOGY (2014)
A Comparative Study of Phosphate Binders in Patients with End Stage Kidney Disease Undergoing Hemodialysis
Viken A. Prajapati et al.
SAUDI JOURNAL OF KIDNEY DISEASES AND TRANSPLANTATION (2014)
Sevelamer Versus Calcium Carbonate in Incident Hemodialysis Patients: Results of an Open-Label 24-Month Randomized Clinical Trial
Biagio Di Iorio et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2013)
Emerging Effects of Sevelamer in Chronic Kidney Disease
Ryota Ikee et al.
KIDNEY & BLOOD PRESSURE RESEARCH (2013)
Phosphate Binder Use and Mortality Among Hemodialysis Patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS): Evaluation of Possible Confounding by Nutritional Status
Antonio Alberto Lopes et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2012)
Effect of Sevelamer and Calcium-Based Phosphate Binders on Coronary Artery Calcification and Accumulation of Circulating Advanced Glycation End Products in Hemodialysis Patients
Takatoshi Kakuta et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2011)
GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables
Gordon Guyatt et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2011)
Lanthanum Carbonate Versus Sevelamer Hydrochloride: Improvement of Metabolic Acidosis and Hyperkalemia in Hemodialysis Patients
Vassilis Filiopoulos et al.
THERAPEUTIC APHERESIS AND DIALYSIS (2011)
Ten-Year Experience with Sevelamer and Calcium Salts as Phosphate Binders
Paolo Raggi et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
Parathyroid hormone improves contractile performance of adult rat ventricular cardiomyocytes at low concentrations in a non-acute way
Ilhan Tastan et al.
CARDIOVASCULAR RESEARCH (2009)
Economic Evaluation of Sevelamer versus Calcium-Based Phosphate Binders in Hemodialysis Patients: A Secondary Analysis using Centers for Medicare & Medicaid Services Data
Wendy L. St. Peter et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
Association of Serum Phosphate with Vascular and Valvular Calcification in Moderate CKD
Kathryn L. Adeney et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
Effects of sevelamer hydrochloride and calcium carbonate on renal osteodystrophy in hemodialysis patients
Anibal Ferreira et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2008)
Effects of sevelamer on the progression of vascular calcification in patients on chronic haemodialysis
Takashi Takei et al.
NEPHRON CLINICAL PRACTICE (2008)
GRADE:: an emerging consensus on rating quality of evidence and strength of recommendations
Gordon H. Guyatt et al.
BRITISH MEDICAL JOURNAL (2008)
Effects of sevelamer and calcium-based phosphate binders on lipid and inflammatory markers in hemodialysis patients
Ronney Shantouf et al.
AMERICAN JOURNAL OF NEPHROLOGY (2008)
A comparative review of the efficacy and safety of established phosphate binders: calcium, sevelamer, and lanthanum carbonate
Stuart M. Sprague
CURRENT MEDICAL RESEARCH AND OPINION (2007)
Fibroblast growth factor 23 (FGF23) predicts progression of chronic kidney disease: The mild to moderate kidney disease (MMKD) study
Danilo Fliser et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
Coronary artery calcification, systemic inflammation markers and mineral metabolism in a peritoneal dialysis population
Adriano Luiz Ammirati et al.
NEPHRON CLINICAL PRACTICE (2006)
Prospective randomized multicenter trial of sevelamer hydrochloride and calcium carbonate for the treatment of hyperphosphatemia in hemodialysis patients in Japan
F Koiwa et al.
THERAPEUTIC APHERESIS AND DIALYSIS (2005)
Two year comparison of sevelamer and calcium carbonate effects on cardiovascular calcification and bone density
HG Asmus et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2005)
Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease
O Gutierrez et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)
Potential antiatherogenic and anti-inflammatory properties of sevelamer in maintenance hemodialysis patients
E Ferramosca et al.
AMERICAN HEART JOURNAL (2005)
Calcium, phosphate, and parathyroid hormone levels in combination and as a function of dialysis duration predict mortality: Evidence for the complexity of the association between mineral metabolism and outcomes
LA Stevens et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2004)
A cross-sectional study of the prevalence and clinical correlates of congestive heart failure among incident US dialysis patients
AG Stack et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2001)
Arterial stiffening and vascular calcifications in end-stage renal disease
AP Guérin et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2000)
Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis
WG Goodman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
分享论文
